An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.